111 related articles for article (PubMed ID: 3011261)
1. Phase II study of mitomycin in small cell lung carcinoma.
McHale MS; Einhorn LH
Cancer Treat Rep; 1986 May; 70(5):675. PubMed ID: 3011261
[No Abstract] [Full Text] [Related]
2. Mitomycin C in advanced adenocarcinoma and large cell carcinoma of the lung.
Samson MK; Comis RL; Baker LH; Ginsberg S; Fraile RJ; Crooke ST
Cancer Treat Rep; 1978 Jan; 62(1):163-5. PubMed ID: 203393
[No Abstract] [Full Text] [Related]
3. Phase II study of 7-N-(p-hydroxyphenyl)-mitomycin C (KW2083) in patients with advanced non-small cell carcinoma of the lung and metastatic pulmonary tumors.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H; Hoshi A
Jpn J Clin Oncol; 1985 Mar; 15(1):61-5. PubMed ID: 3981815
[TBL] [Abstract][Full Text] [Related]
4. [Phase II study of bronchial artery infusion of mitomycin C in non-small cell lung cancer].
Nakamura Y; Shimizu E; Hohjo F; Hashimoto Y; Mutsuura S; Yamasaki K; Mukai J; Tada T; Sone S; Yamashita T
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3436-9. PubMed ID: 3024579
[TBL] [Abstract][Full Text] [Related]
5. [Use of fibrobronchoscopy in the therapeutic evaluation of small-cell pulmonary carcinoma].
Xaubet A; Marín A; Millá A; Sasal M; Solans M; Estapé J; Agustí-Vidal A
Med Clin (Barc); 1983 Dec; 81(20):895-7. PubMed ID: 6319837
[No Abstract] [Full Text] [Related]
6. Treatment of small cell lung cancer with 6-mercaptopurine: a phase II study.
Hansen SW; Skovsgaard T; Sørensen JB
Cancer Treat Rep; 1985 May; 69(5):555. PubMed ID: 2988775
[No Abstract] [Full Text] [Related]
7. Phase II evaluation of amsacrine in small cell lung cancer: a Southeastern Cancer Study Group trial.
Kramer BS; Birch R; Einhorn L; Greco A
Cancer Treat Rep; 1985 Mar; 69(3):333-4. PubMed ID: 2983895
[No Abstract] [Full Text] [Related]
8. [Comparative evaluation of the combined chemotherapy and chemoradiation therapy of patients with a localized form of small-cell lung cancer].
Ausekar BV; Bychkov MB; Mikhina ZP; Shchukina OP
Vestn Akad Med Nauk SSSR; 1986; (5):12-5. PubMed ID: 3014775
[No Abstract] [Full Text] [Related]
9. Phase II study of doxorubicin and mitomycin in non-small cell bronchogenic carcinoma.
Coates AS; Fox RM; Woods RL; Levi JA; Tattersall MH
Cancer Treat Rep; 1982 Jan; 66(1):177-8. PubMed ID: 7053255
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of mitomycin, vinblastine, and cisplatin (MVP) in non-small cell bronchogenic carcinoma.
Schulman P; Budman DR; Weiselberg L; Vinciguerra V; Degnan TJ
Cancer Treat Rep; 1983 Oct; 67(10):943-5. PubMed ID: 6684988
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma.
Jacobs RH; Bitran JD; Deutsch M; Hoffman PC; Sinkule J; Purl S; Golomb HM
Cancer Treat Rep; 1987 Mar; 71(3):311-2. PubMed ID: 3028621
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of vinblastine in small cell carcinoma of the lung.
Sörenson S; Osterlind K; Dombernowsky P; Hansen HH
Cancer Treat Rep; 1983 Mar; 67(3):293-5. PubMed ID: 6299548
[TBL] [Abstract][Full Text] [Related]
13. [Phase II study of KW2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with carcinoma of the lung and metastatic pulmonary tumor].
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Shibuya M; Shimabukuro Z
Gan To Kagaku Ryoho; 1983 Mar; 10(3):834-9. PubMed ID: 6882001
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of vindesine in patients with small cell lung carcinoma.
Natale RB; Gralla RJ; Wittes RE
Cancer Treat Rep; 1981; 65(1-2):129-31. PubMed ID: 6261946
[No Abstract] [Full Text] [Related]
15. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989
[No Abstract] [Full Text] [Related]
16. Ftorafur, adriamycin and mitomycin C (FAM II) for extensive bronchogenic adenocarcinoma and large cell carcinoma.
Salvati F; Cruciani AR; De Marinis A; Nunziati F; Portalone L
Jpn J Clin Oncol; 1984 Mar; 14(1):3-6. PubMed ID: 6323790
[TBL] [Abstract][Full Text] [Related]
17. Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
Joss RA; Brunner KW; Goldhirsch A
Cancer Treat Rep; 1982 Oct; 66(10):1873-4. PubMed ID: 6290051
[No Abstract] [Full Text] [Related]
18. Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group Study.
Miller TP; Weick JK; Grozea PN; Carlin DA
Cancer Treat Rep; 1982 Mar; 66(3):553-6. PubMed ID: 6277487
[TBL] [Abstract][Full Text] [Related]
19. Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer.
Myers JW; Von Hoff DD; Clark GM; Coltman CA
Cancer Treat Rep; 1984 Jun; 68(6):927-8. PubMed ID: 6329511
[No Abstract] [Full Text] [Related]
20. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
